Chronic Kidney Disease Trial, Recruiting NCT07447375 Sponsor: University of Salamanca Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT07447375
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are currently enrolled in a chronic hemodialysis unit.
  • People who have been receiving hemodialysis treatment for more than 3 months.
  • People who are 40 years of age or older.
  • People whose hemoglobin (a measure of red blood cells) level is greater than 10 mg/dl.
  • People who are able to complete physical fitness tests or grip/muscle strength assessments.
  • People who are willing and able to sign a consent form agreeing to take part.

Who may not be able to join:

  • People who experience instability or complications during their dialysis sessions.
  • People with certain medical conditions where exercise is not considered safe, including an active infection, cancer, uncontrolled irregular heart rhythms, or significantly reduced heart pumping function.
  • People with bone, muscle, or breathing problems that get worse with exercise.
  • People who have had a lower limb amputation and do not use a prosthetic limb.
  • People who have had a stroke with lasting effects, or a mini-stroke (a brief episode of stroke-like symptoms) within the past 6 weeks.
  • People with very high blood pressure that is not controlled (top number above 200 or bottom number above 120).
  • People with unstable chest pain (at rest or during activity), or who have had heart bypass surgery or a heart attack within the past 6 weeks.
  • People with diabetes where blood sugar levels are severely out of control (above 300 mg/dl).
  • People who regularly experience low blood pressure during dialysis (below 90/70 mmHg on average).
  • People with psychiatric conditions or cognitive difficulties that would prevent participation in a muscle training program.
  • People who have an arteriovenous fistula (a surgically created connection used for dialysis) located in a lower limb.
  • People with a neurological injury affecting movement that would prevent safe participation in the strength exercises.
  • People who have been hospitalised within the 3 months before the study begins.
  • People who are unlikely to attend sessions regularly, or who are unable to understand the treatment involved (missing more than 25% of sessions would be considered insufficient cooperation).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: María de la Luz Sánchez Tocino, University of Salamanca

Phone: +34 625067971

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Salamanca
Registry
ClinicalTrials.gov
Start date
2 January 2026
Est. completion
31 December 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

> Change in Upper Limb Muscle Strength measured by Handgrip Dynamometry.; Change in Lower Limb Muscle Strength measured by the 5-Times Sit-to-Stand Test (STS5).; Change in Appendicular Skeletal Muscle Mass (ASMM) measured by Bioelectrical Impedance Analysis (BIA).; Change in Physical Performance measured by the Short Physical Performance Battery (SPPB).; Change in Sleep Quality measured by the Pittsburgh Sleep Quality Index (PSQI).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov